论文部分内容阅读
目的观察痰热清注射液治疗急性肺炎的临床疗效。方法选取医院2014年8月-2015年8月收治的急性肺炎患者120例,将其随机分为治疗组和对照组各60例。对照组采用头孢噻肟钠治疗,治疗组采用头孢噻肟钠+痰热清注射液联合治疗,观察2组患者的治疗效果以及白细胞测值改变情况。结果治疗组患者的总有效率为91.7%高于对照组的75.0%,差异有统计学意义(P<0.05)。同时,治疗组治疗前后白细胞、中性粒细胞、淋巴细胞的测值改变情况优于对照组,差异有统计学意义(P<0.05)。结论采用痰热清注射液治疗急性肺炎可显著提高治疗效果,值得推广和应用。
Objective To observe the clinical efficacy of Tanreqing Injection in the treatment of acute pneumonia. Methods A total of 120 patients with acute pneumonia admitted from August 2014 to August 2015 in our hospital were selected and randomly divided into treatment group (60 cases) and control group (60 cases). The control group was treated with cefotaxime sodium. The treatment group was treated with cefotaxime sodium and Tanreqing injection. The therapeutic effect and the change of leukocyte measurement were observed in the two groups. Results The total effective rate of the treatment group was 91.7% higher than that of the control group 75.0%, the difference was statistically significant (P <0.05). At the same time, the changes of leukocyte, neutrophil and lymphocyte in treatment group before treatment were better than those in control group (P <0.05). Conclusion Tanreqing injection for the treatment of acute pneumonia can significantly improve the therapeutic effect, it is worth promoting and application.